financetom
Business
financetom
/
Business
/
IRCTC received Rs 63 crore as convenience fee from rail travellers in September
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IRCTC received Rs 63 crore as convenience fee from rail travellers in September
Nov 16, 2019 4:46 AM

The Indian Railways Catering and Tourism Corporation Ltd (IRCTC) has earned more than Rs 63 crore from convenience fee in September, an RTI query revealed.

Share Market Live

NSE

The central government had decided to scrap the service fee on e-booking of tickets three years ago to promote digital transactions. Before it, the government was charging Rs 20 per ticket on non-AC category and Rs 40 per ticket on air-conditioned tickets.

Defying the decision, the IRCTC imposed the convenience fee from September 1 this year. Thereafter, Rs 15 on non-AC and Rs 30 on air-conditioned tickets are being charged. Moreover, this convenience fee attracts GST additionally.

Right To Information activist Chandrashekhar Gaur filed a query with the IRCTC under the Act asking how much was collected as a service fee on e-ticket bookings between September 1-30. The information provided by the IRCTC to Gaur had mentioned convenience fee in place of a service fee.

According to the IRCTC data, Rs 63.05 crore were received under the convenience fee. However, it was not mentioned that the whole amount was collected from e-booking.

Interestingly, the IRCTC has given three replies to Gaur for his single query. The first reply came on October 22 that said Indian Railways doesn't charge a service fee, instead, IRCTC has imposed convenience fee from September 1, under which a total Rs 51.69 crore were received.

In the second reply on October 30, the IRCTC said that it got Rs 53.54 crore (excluding GST) under the convenience fee in September. Thereafter, while answering the online application on November 1, the IRCTC said that it received a total Rs 63,051,0993 as the fee.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sabadell CEO rules out M&A defence against BBVA bid
Sabadell CEO rules out M&A defence against BBVA bid
May 29, 2024
By Jesús Aguado and Andres Gonzalez MADRID/LONDON (Reuters) - Spain's Sabadell is not planning to try and buy a competitor as part of a potential defence strategy against rival BBVA's hostile takeover attempt, Chief Executive Officer Cesar Gonzalez-Bueno told Reuters. Spain's No. 2 lender BBVA this month stunned Spain by making the first hostile takeover attempt in Spanish banking since...
J&J's treatment for depression succeeds in late stage study
J&J's treatment for depression succeeds in late stage study
May 29, 2024
May 29 (Reuters) - Johnson & Johnson ( JNJ ) said on Wednesday its experimental therapy, seltorexant, met all main and secondary goals in a late-stage study evaluating it in patients with major depressive disorder (MDD) and insomnia symptoms. The therapy was given as a supplemental treatment to antidepressants in the study. ...
Shell, Exxon near deal to sell North Sea assets to Viaro, sources say
Shell, Exxon near deal to sell North Sea assets to Viaro, sources say
May 29, 2024
LONDON, May 29 (Reuters) - Shell and Exxon Mobil ( XOM ) are nearing an agreement to sell their jointly-owned gas fields in the southern North Sea to independent British producer Viaro Energy, three industry and banking sources said. The potential deal is valued around $500 million, one of the sources said. The sale of the Clipper and Leman Alpha...
BioNTech gets $145 mln funding for African vaccine plants
BioNTech gets $145 mln funding for African vaccine plants
May 29, 2024
FRANKFURT, May 29 (Reuters) - COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from a global coalition against infectious diseases to build a production network in Africa for shots based on cutting-edge messenger-RNA (mRNA) technology. BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) said in a joint statement on Wednesday that the financial support was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved